Research may lead to new treatments to prevent preterm birth

December 22, 2016
Credit: Wayne State University

Preterm birth—birth before 37 weeks of pregnancy—affects up to one in every six births in the United States and many other countries. It is the number one cause of infant death and long-term illnesses and imposes heavy social and economic burdens. Although preterm birth is a complex condition, infection of the mother and ensuing inflammation in pregnancy are very common triggers.

In a recent study published in the premier biomedical research journal Nature Medicine, a team of researchers led by Wayne State University's Kang Chen, Ph.D., assistant professor of obstetrics and gynecology in the School of Medicine, discovered the critical function of a type of mother's immune cells—B lymphocytes—in resisting triggered by inflammation.

According to Chen, B lymphocytes make antibodies to defend the body against infections, but scientists and clinicians have always thought these cells are rare or absent in the uterine lining and not important for pregnancy.

Chen's lab discovered that in late pregnancy, mothers' B lymphocytes not only reside in the uterine lining in both humans and mice, but also detect inflammation and uterine stress, which are major causes of preterm birth, and in turn, produce molecules—including one called PIBF1—to suppress uterine inflammation and premature birth.

"This study not only reveals the long-neglected function of B lymphocytes in promoting healthy , but also supports therapeutic approaches of using B lymphocyte-derived molecules—such as PIBF1—to prevent or treat preterm birth," said Chen.

Chen's team has performed proof-of-concept and efficacy studies in animal models, and with the help of the Wayne State University's Technology Commercialization Office, filed a patent for this potential therapeutic approach.

"It is truly remarkable that Kang has independently convened and led a team of outstanding scientists to accomplish this original and impressive tour de force, especially considering the many challenges he has encountered in the process," said Chen's collaborators, who included scientists and clinicians from Wayne State University, Beaumont Hospital Dearborn, Yale University, Memorial Sloan-Kettering Cancer Center, Washington University in St. Louis and Icahn School of Medicine at Mount Sinai. The lead authors are Wayne State postdoctoral fellows Bihui Huang and Azure Faucette, who have both assumed independent positions in academia.

Explore further: Study finds variation of the interval between first and second pregnancy

More information: Bihui Huang et al, Interleukin-33-induced expression of PIBF1 by decidual B cells protects against preterm labor, Nature Medicine (2016). DOI: 10.1038/nm.4244

Related Stories

Silent infections may play role in preterm birth

April 26, 2011

(Medical Xpress) -- Every day, 1,500 babies in the United States are born too early, according to the March of Dimes. Even babies born just a few weeks too soon can face serious health problems and are at risk of lifelong ...

Recommended for you

Technique for 'three-parent baby' revealed

April 3, 2017

Details of a pioneering IVF technique using mitochondrial replacement therapy (MRT) have been revealed, giving hope to those families with inheritable mitochondrial disorders that they may be able to have healthy children ...

Technology to screen embryos before implantation falls short

March 31, 2017

The healthy development of an embryo created through in vitro fertilization (IVF) depends on whether most, if not all, of the cells have the proper number of chromosomes. With pre-implantation genetic screening (PGS) technology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.